Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

M. Reck, M.C. Garassino, M. Imbimbo, F.A. Shepherd, M.A. Socinski, J.-Y. Shih, A. Tsao, P. Lee, K.B. Winfree, A. Sashegyi, R. Cheng, R. Varea, B. Levy, E. Garon

Research output: Contribution to journalArticlepeer-review

Cite this